Tumors: Wounds That Do Not Heal-Redux

被引:377
作者
Dvorak, Harold F. [1 ,2 ,3 ]
机构
[1] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA
[2] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
关键词
VASCULAR-PERMEABILITY FACTOR; ENDOTHELIAL GROWTH-FACTOR; FIBRIN-GEL INVESTMENT; BLOOD-VESSELS; INDUCE ANGIOGENESIS; STROMA GENERATION; FACTOR VPF/VEGF; GUINEA-PIG; VEGF-A; CELLS;
D O I
10.1158/2326-6066.CIR-14-0209
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Similarities between tumors and the inflammatory response associated with wound healing have been recognized for more than 150 years and continue to intrigue. Some years ago, based on our then recent discovery of vascular permeability factor (VPF)/VEGF, I suggested that tumors behaved as wounds that do not heal. More particularly, I proposed that tumors co-opted the wound-healing response to induce the stroma they required for maintenance and growth. Work over the past few decades has supported this hypothesis and has put it on a firmer molecular basis. In outline, VPF/VEGF initiates a sequence of events in both tumors and wounds that includes the following: increased vascular permeability; extravasation of plasma, fibrinogen and other plasma proteins; activation of the clotting system outside the vascular system; deposition of an extravascular fibrin gel that serves as a provisional stroma and a favorable matrix for cell migration; induction of angiogenesis and arterio-venogenesis; subsequent degradation of fibrin and its replacement by "granulation tissue" (highly vascular connective tissue); and, finally, vascular resorption and collagen synthesis, resulting in the formation of dense fibrous connective tissue (called "scar tissue" in wounds and "desmoplasia" in cancer). A similar sequence of events also takes place in a variety of important inflammatory diseases that involve cellular immunity. (C) 2015 AACR.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 82 条
[1]   Stimulation of tumour angiogenesis by proximal wounds: spatial and temporal analysis by MRI [J].
Abramovitch, R ;
Marikovsky, M ;
Meir, G ;
Neeman, M .
BRITISH JOURNAL OF CANCER, 1998, 77 (03) :440-447
[2]   Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment [J].
Allavena, P. ;
Mantovani, A. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2012, 167 (02) :195-205
[3]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[4]   Endothelial gaps: Time course of formation and closure in inflamed venules of rats [J].
Baluk, P ;
Hirata, A ;
Thurston, G ;
Fujiwara, T ;
Neal, CR ;
Michel, CC ;
McDonald, DM .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1997, 272 (01) :L155-L170
[5]  
BARR LC, 1988, LANCET, V2, P135
[6]   Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal [J].
Benjamin, LE ;
Golijanin, D ;
Itin, A ;
Pode, D ;
Keshet, E .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) :159-165
[7]   Scar Carcinoma of the Lung: A Historical Perspective [J].
Bobba, Ravi K. ;
Holly, Jason Scott ;
Loy, Tim ;
Perry, Michael C. .
CLINICAL LUNG CANCER, 2011, 12 (03) :148-154
[8]   Neutrophil extracellular traps kill bacteria [J].
Brinkmann, V ;
Reichard, U ;
Goosmann, C ;
Fauler, B ;
Uhlemann, Y ;
Weiss, DS ;
Weinrauch, Y ;
Zychlinsky, A .
SCIENCE, 2004, 303 (5663) :1532-1535
[9]   EXPRESSION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) BY EPIDERMAL-KERATINOCYTES DURING WOUND-HEALING [J].
BROWN, LF ;
YEO, KT ;
BERSE, B ;
YEO, TK ;
SENGER, DR ;
DVORAK, HF ;
VANDEWATER, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1375-1379
[10]  
BROWN LF, 1988, AM J PATHOL, V130, P455